m6 RNA methylation: an emerging common target in the immune response to cancer and severe acute respiratory syndrome-coronavirus-2 infection

m6A RNA methylation, a predominant type of RNA modification, is involved in regulating mRNA splicing, stability, and translation as well as the interaction between nucleoproteins and noncoding RNAs. Recent studies have revealed that m6A RNA methylation plays a critical role in the self-to-non-self-recognition of immune cells against endogenous mutations in cancer and exogenous organism-related infections. As an epigenetic mechanism, m6A RNA modification induces immune cell signal transduction, which is altered in the tumor microenvironment, as detected in liquid biopsy. Furthermore, m6A RNA methylation-related inflammation is involved in the cellular response to viral infections, including the emerging severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Given the importance of the immune response in maintaining homeostasis in higher eukaryotes, m6A RNA methylation could be useful not only for the early detection of cancer but also for SARS-CoV-2 screening during a global pandemic.

[1]  P. Datta,et al.  Epitranscriptomics of SARS-CoV-2 Infection , 2022, Frontiers in Cell and Developmental Biology.

[2]  Yong‐Chul Kim,et al.  Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells , 2022, Pharmaceuticals.

[3]  C. Morley,et al.  Impact of COVID-19 on Screening Rates for Colorectal, Breast, and Cervical Cancer: Practice Feedback From a Quality Improvement Project in Primary Care. , 2021, Journal of patient-centered research and reviews.

[4]  Wenzhang Wang,et al.  METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events , 2021, Molecular neurodegeneration.

[5]  H. Ishii,et al.  Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer , 2021, Oncotarget.

[6]  R. Gregory,et al.  Mining for METTL3 inhibitors to suppress cancer , 2021, Nature Structural & Molecular Biology.

[7]  C. Tisné,et al.  A comprehensive review of m6A/m6Am RNA methyltransferase structures , 2021, Nucleic acids research.

[8]  T. Rana,et al.  METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection , 2021, Cell Reports.

[9]  K. Haynes,et al.  Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. , 2021, JAMA oncology.

[10]  Andrew J. Bannister,et al.  Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia , 2021, Nature.

[11]  Hua-Bing Li,et al.  Multiple Functions of RNA Methylation in T Cells: A Review , 2021, Frontiers in Immunology.

[12]  M. Landray,et al.  Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study , 2021, The Lancet Gastroenterology & Hepatology.

[13]  Taqiyya Alford,et al.  A review of the efficacy of a low-cost cancer screening test using cancer sniffing canines , 2020, Journal of breath research.

[14]  Linqing Li,et al.  Role of m6A RNA methylation in cardiovascular disease (Review) , 2020, International journal of molecular medicine.

[15]  Qiulian Wu,et al.  The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells. , 2020, Cancer discovery.

[16]  Zhènglì Shí,et al.  Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.

[17]  H. Eguchi,et al.  State-of-the-Art Technology of Model Organisms for Current Human Medicine , 2020, Diagnostics.

[18]  Chuan He,et al.  RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. , 2020, Cell stem cell.

[19]  Richard L. Doty,et al.  Smell dysfunction: a biomarker for COVID‐19 , 2020, International forum of allergy & rhinology.

[20]  X. Zhuang,et al.  m6A-binding YTHDF proteins promote stress granule formation , 2020, Nature Chemical Biology.

[21]  Jianjun Chen,et al.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. , 2020, Cancer cell.

[22]  P. Kubes,et al.  DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation. , 2020, Annual review of pathology.

[23]  Gang Yin,et al.  Functions of N6-methyladenosine and its role in cancer , 2019, Molecular Cancer.

[24]  K. Mimori,et al.  Distinct methylation levels of mature microRNAs in gastrointestinal cancers , 2019, Nature Communications.

[25]  Masateru Taniguchi,et al.  Significant epitranscriptomes in heterogeneous cancer , 2019, Cancer science.

[26]  C. Diaconu,et al.  Recent advances in gastric cancer early diagnosis , 2019, World journal of gastroenterology.

[27]  M. Boruczkowski,et al.  Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy , 2019, Archivum Immunologiae et Therapiae Experimentalis.

[28]  A. Stoita,et al.  Challenges in diagnosis of pancreatic cancer , 2018, World journal of gastroenterology.

[29]  Hongchuan Jin,et al.  N6-methyladenosine links RNA metabolism to cancer progression , 2018, Cell Death & Disease.

[30]  Samie R Jaffrey,et al.  Rethinking m6A Readers, Writers, and Erasers. , 2017, Annual review of cell and developmental biology.

[31]  A. Ruggieri,et al.  m6A RNA methylation, a new hallmark in virus-host interactions. , 2017, The Journal of general virology.

[32]  I. Issa,et al.  Colorectal cancer screening: An updated review of the available options , 2017, World journal of gastroenterology.

[33]  A. Liston,et al.  Homeostasis-altering molecular processes as mechanisms of inflammasome activation , 2017, Nature Reviews Immunology.

[34]  R. Lin,et al.  Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity , 2017, Front. Immunol..

[35]  Saeed Tavazoie,et al.  HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events , 2015, Cell.

[36]  D. Garcin,et al.  RIG-I ATPase Activity and Discrimination of Self-RNA versus Non-Self-RNA , 2015, mBio.

[37]  Chuan He,et al.  Fate by RNA methylation: m6A steers stem cell pluripotency , 2015, Genome Biology.

[38]  Lydia M. Contreras,et al.  Cellular RNA is chemically modified by exposure to air pollution mixtures , 2015, Inhalation toxicology.

[39]  Samie R. Jaffrey,et al.  The dynamic epitranscriptome: N6-methyladenosine and gene expression control , 2014, Nature Reviews Molecular Cell Biology.

[40]  Miao Yu,et al.  A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation , 2013, Nature chemical biology.

[41]  Arne Klungland,et al.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.

[42]  Yun-Gui Yang,et al.  N6-methyl-adenosine (m6A) in RNA: An Old Modification with A Novel Epigenetic Function , 2012, Genom. Proteom. Bioinform..

[43]  Kazushige Touhara,et al.  The scent of disease: volatile organic compounds of the human body related to disease and disorder. , 2011, Journal of biochemistry.

[44]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.

[45]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[46]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[47]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[48]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[49]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[50]  T. Akazawa,et al.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.

[51]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.